Brief: Evonik Invests $100 Million In Its U.S. Drug Substance Contract Manufacturing Site
08/07/2026 13:04
BRIEF-Evonik Invests $100 Million In Its U.S. Drug Substance Contract Manufacturing Site July 8 (Reuters) - EVONIK INDUSTRIES AG EVKn.DE:
TO INVEST US$100 MILLION TO UPGRADE ITS U.S. DRUG SUBSTANCE CONTRACT MANUFACTURING SITE
Source text: ID:nPre8f4p3a
Further company coverage: [EVKn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Evonik Industries AG
See all newsEuropean industry calls for changes to carbon reform to avoid more factory closures
Europe chemicals downturn likely to spur more mergers, Lanxess CEO says
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Europe Research Roundup: Acceler8 Ventures, Hermes, Soitec
Brief: Evonik Invests €52 Mln To Expand Silicone Platform In Essen